U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO recommendation on prophylactic antibiotics for women undergoing caesarean section [Internet]. Geneva: World Health Organization; 2021.

Cover of WHO recommendation on prophylactic antibiotics for women undergoing caesarean section

WHO recommendation on prophylactic antibiotics for women undergoing caesarean section [Internet].

Show details

8References

1.
Global Burden of Disease Injury, Incidence Prevalence, Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. doi:10.1016/S0140-6736(18)32279-7. [PMC free article: PMC6227754] [PubMed: 30496104] [CrossRef]
2.
Global Maternal and Neonatal Sepsis Initiative Working Group. The Global Maternal and Neonatal Sepsis Initiative: a call for collaboration and action by 2030. Lancet Glob Health. 2017;5(4): e390–1. doi:10.1016/S2214-109X(17)30020-7. [PubMed: 28215849] [CrossRef]
3.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–11. doi:10.1016/S0140-6736(19)32989-7. [PMC free article: PMC6970225] [PubMed: 31954465] [CrossRef]
4.
Hussein J, Walker L. Puerperal sepsis in low and middle income settings: past, present and future. In: Kehoe S, Neilson JP, Norman JE, editors. Maternal and infant deaths: chasing millennium development goals 4 and 5. London, United Kingdom: RCOG Press; 2010:131–47.
5.
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969–87. doi: 10.1016/S0140-6736(10)60549-1. [PubMed: 20466419] [CrossRef]
6.
Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet. 2005;365(9462):891–900. doi:10.1016/S0140-6736(05)71048-5. [PubMed: 15752534] [CrossRef]
7.
Kinsey CB, Baptiste-Roberts K, Zhu J, Kjerulff KH. Birth-related, psychosocial, and emotional correlates of positive maternal-infant bonding in a cohort of first-time mothers. Midwifery. 2014;30(5):e188–94. doi:10.1016/j.midw.2014.02.006. [PMC free article: PMC4010321] [PubMed: 24650812] [CrossRef]
8.
Acosta CD, Kurinczuk JJ, Lucas DN, Tuffnell DJ, Sellers S, Knight M, et al. Severe maternal sepsis in the UK, 2011–2012: a national case-control study. PLoS Med. 2014;11(7):e1001672. doi:10.1371/journal.pmed.1001672. [PMC free article: PMC4086731] [PubMed: 25003759] [CrossRef]
9.
van Dillen J, Zwart J, Schutte J, van Roosmalen J. Maternal sepsis: epidemiology, etiology and outcome. Curr Opin Infect Dis. 2010;23(3):249–54. doi:10.1097/QCO.0b013e328339257c. [PubMed: 20375891] [CrossRef]
10.
Owen J, Andrews WW. Wound complications after cesarean sections. Clin Obstet Gynecol. 1994;37(4):842–55. doi:10.1097/00003081-199412000-00009. [PubMed: 7842552] [CrossRef]
11.
Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1–203. doi:10.1111/j.1471-0528.2010.02847.x. [PubMed: 21356004] [CrossRef]
12.
Conroy K, Koenig AF, Yu YH, Courtney A, Lee HJ, Norwitz ER. Infectious morbidity after cesarean delivery: 10 strategies to reduce risk. Rev Obstet Gynecol. 2012;5(2):69–77. [PMC free article: PMC3410505] [PubMed: 22866185]
13.
Seventieth World Health Assembly. Improving the prevention, diagnosis and clinical management of sepsis (WHA70.7). Geneva: World Health Organization; 2017 (http://apps​.who.int/gb​/ebwha/pdf_files/WHA70/A70_R7-en​.pdf?ua=1, accessed 23 March 2021).
14.
Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115(15):E3463–70. doi:10.1073/pnas.1717295115. [PMC free article: PMC5899442] [PubMed: 29581252] [CrossRef]
15.
Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–50. doi:10.1016/S1473-3099(14)70780-7. [PubMed: 25022435] [CrossRef]
16.
Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015 (https://www​.who.int/antimicrobial-resistance​/publications/global-action-plan/en/, accessed 23 March 2021).
17.
Vogel JP, Dowswell T, Lewin S, Bonet M, Hampson L, Kellie F, et al. Developing and applying a ‘living guidelines’ approach to WHO recommendations on maternal and perinatal health. BMJ Glob Health. 2019;4(4):e001683. doi:10.1136/bmjgh-2019-001683. [PMC free article: PMC6703290] [PubMed: 31478014] [CrossRef]
18.
Executive Guideline Steering Group for updating WHO maternal and perinatal health recommendations. Geneva: World Health Organization; 2019 (https://www​.who.int/reproductivehealth​/publications​/updating-mnh-recommendations/en/, accessed 23 March 2021).
19.
WHO handbook for guideline development, second edition. Geneva: World Health Organization; 2014 (https://www​.who.int/groups​/guidelines-review-committee, accessed 23 March 2021).
20.
WHO recommendations for prevention and treatment of maternal peripartum infections. Geneva: World Health Organization; 2015 (https://www​.who.int/reproductivehealth​/publications​/maternal_perinatal_health​/peripartum-infections-guidelines/en/, accessed 23 March 2021). [PubMed: 26598777]
21.
Williams MJ, Carvalho Ribeiro do Valle C, Gyte GML. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database Syst. Rev. 2021; 3:CD008726. doi: 10.1002/14651858.CD008726.pub3. [PMC free article: PMC8092483] [PubMed: 33661539] [CrossRef]
22.
GRADEpro GDT. GRADE your evidence and improve your guideline development in health care [Software]. McMaster University and Evidence Prime Inc. 2020 (https://gradepro​.org/, accessed 23 March 2021).
23.
Eddy K, Vogel J, Comrie-Thomson L, Zahroh R, Bonet M. Preventing infection at birth with antibiotics and antiseptics: a mixed-methods systematic review (protocol). PROSPERO. 2020; CRD42020191746 (https://www​.crd.york​.ac.uk/prospero/display_record​.php?ID=CRD42020191746, accessed 23 March 2021).
24.
Downe S, Finlayson K, Oladapo OT, Bonet M, Gulmezoglu AM. What matters to women during childbirth: a systematic qualitative review. PLoS One. 2018;13(4):e0194906. doi:10.1371/journal.pone.0194906. [PMC free article: PMC5903648] [PubMed: 29664907] [CrossRef]
25.
Knowles R, Sharland M, Hsia Y, Magrini N, Moja L, Siyam A, et al. Measuring antibiotic availability and use in 20 low- and middle-income countries. Bull World Health Organ. 2020;98(3):177–87C. doi:10.2471/BLT.19.241349. [PMC free article: PMC7047034] [PubMed: 32132752] [CrossRef]
26.
Torloni MR, Bonet M, Betran AP, Ribeiro-do-Valle CC, Widmer M. Quality of medicines for life-threatening pregnancy complications in low- and middle-income countries: A systematic review. PLoS One. 2020;15(7):e0236060. doi:10.1371/journal.pone.0236060. [PMC free article: PMC7351160] [PubMed: 32649710] [CrossRef]
27.
Alekwe LO, Kuti O, Orji EO, Ogunniyi SO. Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities. J Matern Fetal Neonatal Med. 2008;21(9):638–42. doi:10.1080/14767050802220490. [PubMed: 18828055] [CrossRef]
28.
Deng D, Yuan W, Ding L, Chen X. Clinical study on coadministration of cefazolin sodium and metronidazole for infection prophylaxis in perioperative period of cesarean section. Pharm Care Res. 2007;7:278–80.
29.
Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care. 2005;21(2):240–5. [PubMed: 15921065]
30.
Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016. doi:10.1136/bmj.i2016. [PubMed: 27353417] [CrossRef]
31.
Lewin S, Booth A, Glenton C, Munthe-Kaas H, Rashidian A, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series. Implement Sci. 2018;13(Suppl 1):2. doi:10.1186/s13012-017-0688-3. [PMC free article: PMC5791040] [PubMed: 29384079] [CrossRef]
32.
Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva: World Health Organization; 2016 (https://www​.who.int/gpsc​/ipc-components/en/, accessed 23 April 2021). [PubMed: 27977095]
33.
Practical guidelines for infection control in health care facilities. Manila/New Delhi: WHO Regional Office for Western Pacific, WHO Regional Office for South-East Asia; 2004 (https://www​.who.int/publications​/i/item/practical-guidelines-for-infection-control-in-health-care-facilities, accessed 23 March 2021).
34.
WHO recommendations on postnatal care of the mother and newborn. Geneva: World Health Organization; 2013 (https://www​.who.int/maternal​_child_adolescent​/documents/postnatal-care-recommendations/en/, accessed 23 March 2021). [PubMed: 24624481]
35.
World Health Organization Model List of Essential Medicines for Children. 7th List 2019. Geneva: World Health Organization; 2019 (https://www​.who.int/publications​/i/item/WHOMVPEMPIAU201907, accessed 23 April 2021).
36.
WHO global strategy for containment of antimicrobial resistance. Geneva: World Health Organization; 2001 (https://www​.who.int/drugresistance​/WHO_Global_Strategy​.htm/en/, accessed 23 March 2021).
37.
Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 199: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol. 2018;132(3):e103–19. doi:10.1097/AOG.0000000000002833. [PubMed: 30134425] [CrossRef]
38.
WHO recommendations on interventions to improve preterm birth outcomes. Geneva, Switzerland: World Heatlh Organization; 2015 (https://www​.who.int/reproductivehealth​/publications​/maternal_perinatal_health​/preterm-birth-guideline/en/, accessed 20 April 2021). [PubMed: 26447264]
39.
Standards for improving quality of maternal and newborn care in health facilities. Geneva: World Health Organization; 2016 (https://www​.who.int/maternal​_child_adolescent​/documents/improving-maternal-newborn-care-quality/en/, accessed 23 March 2021).
40.
Evaluating the quality of care for severe pregnancy complications: the WHO near-miss approach for maternal health. Geneva: World Health Organization; 2011 (https://apps​.who.int​/iris/handle/10665/44692, accessed 23 March 2021).
© World Health Organization 2021.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).

Bookshelf ID: NBK571482

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...